Clinical Trials Directory

Trials / Sponsors / Alebund Pharmaceuticals

Alebund Pharmaceuticals

Industry · 6 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease)
Phase 32025-06-13
Not Yet RecruitingA Study to Evaluate Safety, Tolerability and Efficacy of AP306 At Fixed Doses in Patients with Hyperphosphatem
Hyperphosphatemia, Chronic Kidney Disease Requiring Hemodialysis
Phase 22025-04-10
RecruitingA Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
Diabetic Kidney Disease
Phase 12025-02-27
CompletedA Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants
Healthy Subjects
Phase 12024-03-18
CompletedAP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
ESRD (End Stage Renal Disease), Chronic Kidney Disease(CKD), Hyperphosphatemia
Phase 32023-06-12
CompletedA Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients
Chronic Kidney Diseases, Hyperphosphatemia
Phase 22023-02-20